Results

Total Results: 1,401 records

Showing results for "adverse".

401. Prostate-Cancer-Therapies-Update Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_research-protocol.pdf
     April 01, 2013 - the likely trade-offs a patient must make between estimated treatment effectiveness, necessity, and adverse … ://effectivehealthcare.ahrq.gov Posted Online: March 29, 2013 Page 6 treatment options result in adverse … For adverse events, we will also include large nonrandomized comparative studies that reported relevant … We will focus primarily on common and severe adverse events of treatment including bowel, bladder, and … Summaries of effectiveness and adverse-event outcomes with ranges according to treatment option, tumor

402. Autism-Adolescents Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-adolescents_executive.pdf
     August 01, 2012 - the Agency for Healthcare Research and Quality (AHRQ) Effective Health Care program as all possible adverse … Finally, interventions may be associated with harms/adverse effects. … complaints, weight gain, increased appetite, fatigue, dystonia, and depression.21,40,44 Adverse effects … As in the case of efficacy, the data on adverse effects associated with risperidone, including sedation … Of course, this does not mean that other medications tested in ASD are free of adverse effects.

403. AHRQ’s Evidence-based Practice Center Program Annual Report 2023 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2023.pdf
     January 01, 2023 - Inform CMS Coverage Decision for Dental Care EPC Report: Efficacy of Dental Services for Reducing Adverse … Efficacy of Dental Services for Reducing Adverse Events in Those Receiving Chemotherapy for Cancer 3 … Efficacy of Dental Services for Reducing Adverse Events in Those Undergoing Insertion of Implantable … Association Between Angiotensin Receptor Blocker Drug Recalls and Adverse Clinical Outcomes in Patients … Adverse Events Associated With COVID-19 Pharmaceutical Treatments 2.

404. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-frameworks.ppt
     June 01, 2012 - Potential adverse consequences of testing. … What are possible adverse consequences of testing? … Adverse events, acceptability of test procedure? … Adverse events of subsequent treatment/ other tests? … To understand potential adverse consequences of testing. All of the above.

405. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-frameworks.ppt
     June 01, 2012 - Potential adverse consequences of testing. … What are possible adverse consequences of testing? … Adverse events, acceptability of test procedure? … Adverse events of subsequent treatment/ other tests? … To understand potential adverse consequences of testing. All of the above.

406. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypothyroidism-hyperthyroidism-screening-treatment_research-protocol.pdf
     March 11, 2010 - possible association with increased miscarriage and neuropsychological complications in offspring, the adverse … • Adverse events i. Psychological or social impact of false positive screening tests. ii. … Adverse reactions are usually due to therapeutic overdosage and resulting hyperthyroidism. … Title/Abstract] OR random allocation[MeSH Terms] OR therapeutic use[MeSH Subheading]) H Harms 1. adverse … OR side-effect$ OR undesirable effect$ OR treatment emergent OR tolerability OR toxicity) [tw] 8. adverse

407. Methods Guide for Medical Test Reviews Chapter 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-outcomes_methods.pdf
     July 01, 2012 - (Table 3–1) To illustrate, the adverse emotional effects, and the legal and ethical outcomes of testing … screening tests are conducted in individuals who are without symptoms of the disease of interest, so any adverse … addressed whether screening for bacterial vaginosis during pregnancy in asymptomatic women reduces adverse … These included adverse effects of therapies and beneficial effects—reduction in adverse pregnancy outcomes … Spirometry has few direct test effects, although patients can have adverse reactions to testing, particularly

408. Gout Dx protocol_140715-draft (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol-2014.pdf
     January 01, 2014 - What are the adverse effects associated with each diagnostic test (including pain, infection at the … patient global assessment, and activity limitations (KQ1,2)10 o Adverse effects of the tests, including … symptom relief: 1-2 days minimum (KQ1) o Early in a flare vs. later or post-flare (KQ1c) o For adverse … events (including adverse patient experiences such as pain or infection at the aspiration site, effects … Prospective cohort, case control, and case series of any size, as well as case reports of rare adverse

409. Trauma Informed Care: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-informed-care-executive-summary.pdf
     January 01, 2025 - Systematic Review Executive Summary Main Points Background and Purpose Exposure to adverse … Studies did not report harms, adverse events, or unintended consequences of TIC.

410. Emerging MRI Technologies for Imaging Musculoskeletal Disorders under Loading Stress (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-disorders-imaging_disposition-comments.pdf
     November 01, 2011 - The label of "Adverse event" for this column does not seem appropriate- some are more patient limitations … We believe “Adverse events” to be an accurate description of the information contained in the Table … We have also expanded the description of adverse events in the main text. … vs. an adverse event related to the safety of the device or procedure? … False negatives are not considered as adverse events associated with testing.

411. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-patient-family-engagement.pdf
     July 01, 2023 - patient and family perspectives can be incorporated into patient safety, ultimately reducing risks for adverse … concurrent or historical comparison group • No clear description of intervention Outcome Safety • Adverse … The missing evidence: a systematic review of patients' experiences of adverse events in health care … Promoting engagement by patients and families to reduce adverse events in acute care settings: a systematic

412. Chronic-Cough Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_executive.pdf
     March 01, 2014 - , as well as demographic and other data needed for determining outcomes (intermediate, final, and adverse … The safety outcomes were framed to help identify adverse events from drug therapies and nonpharmacological … • All preparations appeared to be well-tolerated, but side effects and adverse events were uncommonly … reported; underreporting side effects and adverse events could limit the assessment of effectiveness … The LCQ and the CQLQ along with its predecessor, the Adverse Cough Outcome Survey [ACOS]), are the

413. EHC Protocol: Recurrent Nephrolithiasis in Adults and Children: Comparative Effectiveness of Preventive Medical Strategies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-protocol.pdf
     September 24, 2024 - visits and hospitalizations, quality of life, missed school or work, preventive treatment- related adverse … events, imaging-related adverse events, serious adverse events, discontinuations due to adverse events … visits and hospitalizations, quality of life, missed school or work, preventive treatment-related adverse … events, imaging- related adverse events, serious adverse events, discontinuations due to adverse events … stone events (e.g., urinary obstruction, infection) Quality of life Serious treatment- related adverse

414. Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin - Executive Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-199-skin-cancer.pdf
     December 01, 2017 - • Serious adverse events, events leading to treatment discontinuation, and treatment site infections … Adverse Events, All BCC Lesions In Table B drugs were most likely to have adverse events leading to … Events Leading to Discontinuation (95% CI) Serious Adverse Events (95% CI) Adverse Events: … Adverse Events, All SCCIS Lesions In Table C the highest mean frequency of adverse events leading to … Adverse events were inconsistently reported.

415. Interventions for Breathlessness in Patients With Advanced Cancer: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dyspnea-advanced-cancer-summary-1.pdf
     November 01, 2020 - • Both nonpharmacological and pharmacological interventions led to adverse event-related dropouts … • Adverse effects led to dropouts among a small percentage of patients for all types of pharmacological

416. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
     January 01, 2020 - • Adverse effects of approaches including burden of approach, nutritional deficiencies or eating … disorders, activity related injuries including fracture, and adverse events of medications (e.g., diarrhea … • For intermediate outcomes, adverse effects and quality of life, additional time points of interest … effect of medication • Other adverse effects Interventions Self-management (KQ 1), Dietary … • Obesity-related clinical outcomes, intermediate outcomes, adverse effects and quality of life

417. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive-2007.pdf
     January 01, 2007 - What adverse events and complications have been associated with aggressive medical therapy or renal artery … • The evidence does not adequately assess comparisons of adverse events between medical treatment

418. Hypertension-Pulmonary-Arterial Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-pulmonary-arterial_research-protocol.pdf
     January 30, 2013 - Cambridge Pulmonary Hypertension Outcome Review [CAMPHOR])  Right heart failure  Mortality Adverse … , CAMPHOR)  Prevention of right ventricular dysfunction and/or right heart failure  Mortality Adverse … failure • Mortality Analytic framework for pulmonary arterial hypertension (KQs 1, 2) KQ 1 Bi Adverse … Calcium-channel blockers • Prostanoids • Endothelin antagonists • Phosphodiesterase inhibitors Bi Adverse … No primary or secondary outcomes of interest are reported Outcomes (safety) • KQs 1 and 2: Adverse

419. high-cholesterol-medicines-update-protocol-130516 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
     December 31, 2013 - 23 In addition, the use of multiple agents in combination therapy may increase the risk of serious adverse … , this comparative effectiveness review (CER) will address long-term benefits and rates of serious adverse … The previous CER initially intended to examine the long-term benefits and rates of serious adverse effects … death, hospitalization, disability, or a birth defect)  Participants experiencing at least one adverse … event; withdrawal due to an adverse event; cancer; serum AST and/or serum ALT elevated ≥ 3 times

420. Cannabis-2022-Update-Surv-Rep-1-App-F1-4 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
     January 01, 2022 - Adverse Events Table F-4. … Any Adverse Event Intervention B, N of Any Adverse Event (Numerator) Intervention B, N Analyzed for … A, % With Serious Adverse Event Intervention B, N of Serious Adverse Event (Numerator) Intervention … to Adverse Event (Denominator) Intervention A, % With Withdrawals Due to Adverse Event Intervention B … Adverse Event (Denominator) Intervention B, % With Withdrawals Due to Adverse Event Intervention A,